Discover five steps required to help create a compelling business case and get the key facts and figures you need to achieve senior buy-in for a digitalized QC Platform.
Dive into excellence: Discover how FDA's QMM program & CDER's rating system empower CDMOs to ensure top-quality pharmaceuticals, prevent shortages & build reliability. Uncover...
Contamination can lead to costly recalls, a damaged reputation, and ultimately harm to customers. Learn how to check your weighing equipment for key hygienic features and find...
What if you could achieve faster off-gas composition analysis without sacrificing precision and quality? Learn how to gain improved precision, accuracy, long intervals between...
With many pharma manufacturers operating sophisticated (and costly) continuous water purification systems, results that come days after a sample has been taken do little to ensue...
Bringing the Pharma industry closer to it's CAPA goals requires a systematic approach. This special report presents the results and analysis of a recent industry survey indicating...
An important part of validating the safety function in a level instrument is the requirement for regular proof testing. However, full testing can lead to increased risk and process...
Dr. Hussain's recent presentation at the 28th Annual Midwest Biopharmaceutical Statistical Workshop at Ball State University provides a detailed overview of how Six Sigma principles...
This document provides guidance to industry on good pharmacovigilance practices and pharmacoepidemiologic assessment, specifically on (1) safety signal identification, (2) pharmacoepide...
Built-in ability to meet data integrity standards should be a central focus when selecting control systems and manufacturing execution systems for pharma manufacturing
Upholding rigorous quality standards is not only a regulatory imperative but also vital for ensuring the efficacy and safety of pharmaceutical products. And as many pharma manufacturers...
Nine out of 10 Fortune 500 executives surveyed expressed interest in the idea of outsourcing energy operations to reduce risk. Learn how an Energy as a Service model can support...
Discover how Blue Mountain's Regulatory Asset Manager (RAM) propelled AmplifyBio, a leading Contract Research Organization (CRO), into a paperless future.
mRNA-LNP manufacturing is fraught with obstacles, resulting in higher program risk, inflated costs, and delayed market release. With the right knowledge, companies can overcome...
During tableting processes, APIs become airborne. These dust particles can harm workers, reduce air quality, contaminate products and cause explosions. Learn how dust collectors...
